Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 4801 - 4825 of 9176 in total
Sifalimumab is a fully human monoclonal antibody targeting interferon-alpha. The levels of interferon-alpha are elevated in many patients with active systemic lupus erythematosus (SLE, or lupus) and other autoimmune disorders, and may be associated with disease activity. Sifalimumab may suppress the abnormal immune activity associated with lupus by binding to...
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Experimental
Matched Categories: … Amino Alcohols …
Anfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial).
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Tomaralimab is under investigation in clinical trial NCT01794663 (Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function).
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Pentaglobin, also known as IgM-enriched immunoglobulin, falls under a group of polyclonal immunoglobulin preparations. It is comprised of immunoglobulin G (IgG) (https://www.drugbank.ca/drugs/DB00028) and immunoglobulin A (IgA) while also being enriched by immunoglobulin M (IgM).
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Batoclimab is under investigation in clinical trial NCT04428255 (A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP).
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Eflepedocokin alfa is a recombinant IL-22-Fc fusion protein manufactured in Chinese hamster ovary cells that is composed of 2 human interleukin 22 (IL-22) molecules linked to an immunoglobulin constant region (IgG2-Fc).[A225706, L27661] It is being developed by Evive Biotech (previously known as Generon BioMed Inc).
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
AVP-21D9 is a fully human anthrax monoclonal antibody that is being investigated as an anthrax antitoxin.
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Mapatumumab is under investigation in clinical trial NCT00094848 (Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-hodgkin's Lymphoma (NHL)).
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Experimental
Matched Iupac: … (2S)-2-amino-3-(naphthalen-2-yl)propanoic acid …
Alaproclate was developed as one of the first selective serotonin reuptake inhibitor (SSRI) antidepressants by Astra AB (now AstraZeneca) in the 1970s. Development was discontinued due to concerns over hepatotoxicity observed in animal studies. Alaproclate has also been found to act as a non-competitive NMDA receptor antagonist although without discriminative...
Experimental
Matched Categories: … Amino Acids ... Amino Acids, Peptides, and Proteins …
Experimental
Matched Iupac: … 2-ethylhexyl 4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino ... ]-1,3,5-triazin-2-yl)amino]benzoate …
Experimental
Matched Iupac: … (2S)-2-amino-3-(1,10-phenanthrolin-2-yl)propanoic acid …
Experimental
Matched Iupac: … (5R)-5-({10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}amino)-1,2,5,6,7,8-hexahydroquinolin-2-one …
QGC001 has been used in trials studying the treatment of Essential Hypertension.
Investigational
Matched Iupac: … (3S)-3-amino-4-{[(2S)-2-amino-4-sulfobutyl]disulfanyl}butane-1-sulfonic acid …
Experimental
Illicit
Experimental
Experimental
Matched Iupac: … (2S,4S)-2-amino-5-fluoro-4-methylpentanoic acid …
Experimental
Matched Iupac: … (2S,3S)-2-amino-3-hydroxy-4-(phosphonooxy)butanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-3-[(2S)-oxiran-2-yl]propanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-sulfinylpropanoic acid …
Experimental
Displaying drugs 4801 - 4825 of 9176 in total